Skip to content
10-Q

Quarterly Report

LATAMED AI CORP. LMED

0001477932-24-007461

← back to feed
Filed
Nov 19, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 14, 2024 243.72K sh
Current Liabilities Q3 2024 · Sep 30, 2024 $647.97K
Current Liabilities Q3 2024 · Dec 31, 2023 $500.36K
Total Liabilities Q3 2024 · Sep 30, 2024 $647.97K
Total Liabilities Q3 2024 · Dec 31, 2023 $500.36K
Current Assets Q3 2024 · Sep 30, 2024 $0
Current Assets Q3 2024 · Dec 31, 2023 $0
Total Assets Q3 2024 · Sep 30, 2024 $0
Total Assets Q3 2024 · Dec 31, 2023 $0
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$28.83K
Cash And Equivalents Q3 2024 · Sep 30, 2023 $0
Cash And Equivalents Q3 2024 · Dec 31, 2022 $0
Stockholders Equity Q3 2024 · Sep 30, 2023 $454.41K
Stockholders Equity Q3 2024 · Jun 30, 2023 $464.75K
Stockholders Equity Q3 2024 · Mar 31, 2023 −$391.38K
Stockholders Equity Q3 2024 · Dec 31, 2022 −$373.64K
Sga Expense Q3 2024 · Sep 30, 2023 $2.93M
Sga Expense Q3 2024 · Sep 30, 2023 $2.93M
Net Income Q3 2024 · Sep 30, 2023 −$2.94M
Net Income Q3 2024 · Jun 30, 2023 −$18.87K
Net Income Q3 2024 · Mar 31, 2023 −$17.74K
Operating Income Q3 2024 · Sep 30, 2023 −$2.94M
Operating Income Q3 2024 · Sep 30, 2023 −$2.96M
Revenue Q3 2024 · Sep 30, 2023 $0
Revenue Q3 2024 · Sep 30, 2023 $0